帕金森病市场的脑深部刺激疗法：副产品（双通道、单通道）、最终用户（门诊手术中心、医院、神经科诊所）-俄罗斯-乌克兰衝突和高通胀-2023-2030年全球市场预测

预计帕金森病脑深部刺激疗法的全球市场将在 2023 年达到 10.751 亿美元，复合年增长率为 15.33%，预计到 2030 年将大幅增长，达到 29.3075 亿美元。

FPNV定位矩阵

FPNV定位矩阵对于评估全球帕金森病市场深部脑刺激疗法至关重要。 通过检查业务战略和产品满意度的关键指标，我们对供应商进行全面评估，使您能够根据您的具体需求做出明智的决策。 这种高级分析将供应商分为四个像限，并取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市场份额分析

市场份额分析可以深入了解供应商在特定市场区域的当前状态。 比较供应商对整体收入、客户群和其他关键指标的贡献，可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。 该分析还揭示了特定行业的竞争程度、积累和分散的优势以及研究基准年的合併特征。

本报告提供了以下几点见解：

1. 市场渗透率：提供有关主要公司所服务的市场的全面信息。

2. 市场开发：提供有关利润丰厚的新兴市场的详细信息，并分析其在成熟市场领域的渗透率。

3. 市场多元化：提供有关新产品发布、未开发地区、最新开发和投资的详细信息。

4. 市场趋势：全面了解 COVID-19、俄罗斯-乌克兰衝突和高通胀的累积影响。

5.竞争评估和信息：对主要公司的市场份额、战略、产品、认证、监管状况、专利状况、製造能力进行综合评估。

6. 产品开发和创新：提供对未来技术、研发活动和突破性产品开发的见解。

此报告回答了以下问题：

1.帕金森病脑深部刺激治疗的全球市场规模和预测是多少？

2. 在预测期内，COVID-19 影响全球帕金森病深部脑刺激疗法市场的抑制因素和影响是什么？

3.在预测期内，全球帕金森病脑深部刺激疗法市场需要投资哪些产品/细分市场/应用/领域？

4.帕金森病脑深部刺激治疗全球市场的竞争策略是什么？

5.帕金森病脑深部刺激治疗全球市场的技术趋势和监管框架是什么？

6. 全球帕金森病脑深部刺激治疗市场主要厂商的市场份额是多少？

7. 哪些形式和战略举措被认为适合进入帕金森病脑深部刺激疗法的全球市场？

目录

第一章前言

第二章研究方法

第 3 章执行摘要

第四章市场概述

第 5 章市场洞察

• 市场动态
  • 促进因素
    • 神经系统疾病的发生率增加
    • 人口迅速老龄化正在增加神经系统疾病的风险和患病率
    • 微创手术日益普及
  • 抑制因素
    • 复杂的监管框架
  • 机会
    • 设备技术进步
    • 神经学研究和开发的激增
  • 作业
    • 深部脑刺激手术的并发症
• 市场趋势
• 新冠肺炎 (COVID-19) 的累积影响
• 俄罗斯-乌克兰衝突的累积影响
• 高通胀的累积影响
• 波特五力分析
• 价值炼和关键路径分析
• 监管框架
• 客户定制

第6 章帕金森病市场中的深部脑刺激疗法：副产品（双通道、单通道）、最终用户（门诊手术中心、医院、神经科诊所）- 俄罗斯-乌克兰衝突和高通货膨胀- 全球市场：By产品

• 双通道
• 单通道

第7 章帕金森病市场的深部脑刺激疗法：副产品（双通道、单通道）、最终用户（门诊手术中心、医院、神经科诊所）- 俄罗斯-乌克兰衝突和高通货膨胀- 全球市场：最终用户

• 门诊手术中心
• 医院
• 神经科诊所
• 研究中心

第 8 章：美洲帕金森病的脑深部刺激治疗市场：副产品（双通道、单通道）、最终用户（门诊手术中心、医院、神经科诊所） - 俄罗斯-乌克兰衝突和高通货膨胀 -世界市场

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美国

第9章亚太地区帕金森病脑深部电刺激治疗市场：副产品（双通道、单通道）、最终用户（门诊手术中心、医院、神经内科诊所） - 俄罗斯-乌克兰衝突和高通胀- 世界市场

• 澳大利亚
• 中国
• 印度
• 印度尼西亚
• 日本
• 马来西亚
• 菲律宾
• 新加坡
• 韩国
• 台湾
• 泰国
• 越南

第 10 章欧洲、中东和非洲帕金森病脑深部刺激治疗市场：副产品（双通道、单通道）、最终用户（门诊手术中心、医院、神经科诊所）- 俄罗斯-乌克兰衝突和高风险通货膨胀- 世界市场

• 丹麦
• 埃及
• 芬兰
• 法国
• 德国
• 以色列
• 意大利
• 荷兰
• 尼日利亚
• 挪威
• 波兰
• 卡塔尔
• 俄罗斯
• 沙特阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯联合酋长国
• 英国

第11章竞争态势

• FPNV定位矩阵
• 市场份额分析：按主要公司划分
• 竞争情景分析：主要公司

第12章上市公司名单

第13章附录

• 讨论指南
• 关于许可证和价格

The Global Deep Brain Stimulation in Parkinson's Disease Market is forecasted to grow significantly, with a projected USD 1,075.10 million in 2023 at a CAGR of 15.33% and expected to reach a staggering USD 2,930.75 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Deep Brain Stimulation in Parkinson's Disease Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Deep Brain Stimulation in Parkinson's Disease Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Dual Channel and Single Channel. The Dual Channel is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Ambulatory Surgical Centers, Hospitals, Neurology Clinics, and Research Centers. The Ambulatory Surgical Centers is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Deep Brain Stimulation in Parkinson's Disease Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Deep Brain Stimulation in Parkinson's Disease Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Deep Brain Stimulation in Parkinson's Disease Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Deep Brain Stimulation in Parkinson's Disease Market?

4. What is the competitive strategic window for opportunities in the Global Deep Brain Stimulation in Parkinson's Disease Market?

5. What are the technology trends and regulatory frameworks in the Global Deep Brain Stimulation in Parkinson's Disease Market?

6. What is the market share of the leading vendors in the Global Deep Brain Stimulation in Parkinson's Disease Market?

7. What modes and strategic moves are considered suitable for entering the Global Deep Brain Stimulation in Parkinson's Disease Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Deep Brain Stimulation in Parkinson's Disease Market, by Product, 2022 vs 2030
• 4.3. Deep Brain Stimulation in Parkinson's Disease Market, by End-User, 2022 vs 2030
• 4.4. Deep Brain Stimulation in Parkinson's Disease Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing incidences of neurological diseases
    • 5.1.1.2. Rapidly aging population, leading to risk and high prevalence of neurological disorders
    • 5.1.1.3. Rising popularity of minimally invasive procedures
  • 5.1.2. Restraints
    • 5.1.2.1. Complex regulatory framework
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing technological advancement in devices
    • 5.1.3.2. Surge in neurological R&D
  • 5.1.4. Challenges
    • 5.1.4.1. Complications of deep brain stimulation surgery
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Deep Brain Stimulation in Parkinson's Disease Market, by Product

• 6.1. Introduction
• 6.2. Dual Channel
• 6.3. Single Channel

7. Deep Brain Stimulation in Parkinson's Disease Market, by End-User

• 7.1. Introduction
• 7.2. Ambulatory Surgical Centers
• 7.3. Hospitals
• 7.4. Neurology Clinics
• 7.5. Research Centers

8. Americas Deep Brain Stimulation in Parkinson's Disease Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Deep Brain Stimulation in Parkinson's Disease Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Deep Brain Stimulation in Parkinson's Disease Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. FPNV Positioning Matrix
• 11.2. Market Share Analysis, By Key Player
• 11.3. Competitive Scenario Analysis, By Key Player

12. List of Company Mentioned

13. Appendix

• 13.1. Discussion Guide
• 13.2. License & Pricing

1. Abbott Laboratories

2. Aleva Neurotherapeutics SA

3. Beijing Pins Medical Co.,Ltd.

4. Boston Scientific Corporation

5. Functional Neuromodulation Ltd.

6. General Electric Co.

7. Medtronic PLC

8. MicroTransponder Inc.

9. Neuronetics Inc.

10. NeuroPace Inc.

11. NeuroSigma, Inc.

12. Nexstim Oy

13. Renishaw PLC

14. Siemens AG

15. St. Jude Medical, Inc.

16. Synapse Biomedical Inc.

LIST OF FIGURES

• FIGURE 1. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET RESEARCH PROCESS
• FIGURE 2. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2022 VS 2030
• FIGURE 3. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
• FIGURE 5. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
• FIGURE 6. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 7. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET DYNAMICS
• FIGURE 8. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 9. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. ASIA-PACIFIC DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. EUROPE, MIDDLE EAST & AFRICA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 15. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 5. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY DUAL CHANNEL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY SINGLE CHANNEL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 8. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY NEUROLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY RESEARCH CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. AMERICAS DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 13. AMERICAS DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 14. AMERICAS DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 15. ARGENTINA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 16. ARGENTINA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 17. BRAZIL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 18. BRAZIL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 19. CANADA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 20. CANADA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 21. MEXICO DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 22. MEXICO DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 23. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 24. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 25. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 26. ASIA-PACIFIC DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 27. ASIA-PACIFIC DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 28. ASIA-PACIFIC DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 29. AUSTRALIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 30. AUSTRALIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 31. CHINA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 32. CHINA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 33. INDIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 34. INDIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 35. INDONESIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 36. INDONESIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 37. JAPAN DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 38. JAPAN DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 39. MALAYSIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 40. MALAYSIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 41. PHILIPPINES DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 42. PHILIPPINES DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 43. SINGAPORE DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 44. SINGAPORE DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 45. SOUTH KOREA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 46. SOUTH KOREA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. TAIWAN DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 48. TAIWAN DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 49. THAILAND DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. THAILAND DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 51. VIETNAM DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 52. VIETNAM DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. EUROPE, MIDDLE EAST & AFRICA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 54. EUROPE, MIDDLE EAST & AFRICA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. EUROPE, MIDDLE EAST & AFRICA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. DENMARK DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 57. DENMARK DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. EGYPT DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 59. EGYPT DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 60. FINLAND DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. FINLAND DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. FRANCE DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 63. FRANCE DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 64. GERMANY DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 65. GERMANY DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 66. ISRAEL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. ISRAEL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. ITALY DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. ITALY DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. NETHERLANDS DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 71. NETHERLANDS DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 72. NIGERIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. NIGERIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. NORWAY DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 75. NORWAY DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 76. POLAND DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. POLAND DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. QATAR DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 79. QATAR DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. RUSSIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. RUSSIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 82. SAUDI ARABIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 83. SAUDI ARABIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 84. SOUTH AFRICA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 85. SOUTH AFRICA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 86. SPAIN DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. SPAIN DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 88. SWEDEN DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 89. SWEDEN DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. SWITZERLAND DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. SWITZERLAND DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 92. TURKEY DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. TURKEY DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. UNITED ARAB EMIRATES DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 95. UNITED ARAB EMIRATES DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. UNITED KINGDOM DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. UNITED KINGDOM DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 98. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 99. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 100. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET LICENSE & PRICING